President Donald Trump is facing pressure to use his executive power to block hospitals from denying organ transplants for people not vaccinated against COVID-19 after reports emerged that Vice President JD Vance’s 12-year-old relative was reportedly denied a heart transplant over her COVID-19 vaccination status
In a letter to President Trump, Rep. Michael Rulli (R-Ohio) alongside Rep. Erin Houchin (R-Ind.) called on Trump to take action. Rep. Rulli said he was partially moved to act after hearing about Vance’s relative.
“Over the past week, it has come to light that multiple desperate Americans have been denied life-saving organ transplants due to their COVID-19 vaccination status,” the letter said. “This outrageous denial of care has affected some of our most vulnerable citizens – including a child from Indiana and a veteran from Ohio.”
Houchin told Fox News, “Patients – especially children – should never be turned away from care due to government-imposed mandates. This effort urges President Trump to take action to ensure no hospital or transplant center can discriminate against patients based on their decision to decline the COVID-19 vaccine.”
“President Trump has done such a great job recently on executive orders,” Rulli told Fox News Digital in an interview. “And I am asking President Trump if he sees this, to please do an executive order… because you could save someone’s life today.”
“The timing is everything. If we don’t get this done, people’s lives could be at risk.”
The girl’s mother, Jeneen Deal, told the Daily Mail that giving her daughter the vaccine would violate the family’s religious beliefs.
Vance said in comments to the Daily Mail that he would try to help.
“I guess it’s been circulating on social media, but I was made aware of a couple days ago, and we’re trying to dig in and trying to help, obviously, as much as possible,” he said.
White House Chief of Staff Susie Wiles delivers remarks during the Memorial Service for Charlie Kirk at State Farm Stadium in Glendale, Arizona, Sunday, September 21, 2025.(Official White House Photo by Daniel Torok)
White House Chief of Staff Susie Wiles announced Wednesday that she is cancer-free, six months after disclosing her early-stage breast cancer diagnosis.
“After a medical appointment at the Mayo Clinic this week, my pathology results came back clear,” Wiles wrote in a post on X. “I am cancer free.”
Some personal news I’m grateful to share. After a medical appointment at the Mayo Clinic this week, my pathology results came back clear.
I am cancer free.
Thank you to my family, friends, doctors, and everyone who prayed for me, checked in, and supported me along the way.
Wiles thanked her family, friends, doctors and those who prayed for and supported her during treatment.
She also offered “a special thank you” to President Donald Trump for his “unwavering support,” adding that she would continue working to advance his America First agenda.
Wiles revealed her diagnosis in March and continued carrying out her duties during treatment. She returned to work shortly after undergoing a cancer-related medical procedure at the Mayo Clinic earlier this week, CBS News reported.
(Nova York - EUA, 24/09/2019) Presidente da República, Jair Bolsonaro, durante encontro com o senhor Rudolph Giuliani, ex-prefeito da cidade de Nova York. .Foto: Alan Santos/PR
Former New York City Mayor Rudy Giuliani has reportedly left the intensive care unit, according to his spokesperson, after being hospitalized with pneumonia.
Giuliani “will spend some time recovering before leaving the hospital,” spokesperson Ted Goodman said in a statement, adding: “The mayor and his family appreciate the outpouring of love and prayers sent his way.”
Giuliani had been hospitalized in critical condition earlier this week, his spokesperson said Sunday.
Dr. Maria Ryan told Fox News that Giuliani’s condition had deteriorated rapidly after he returned from a trip to Paris, with severe breathing issues forcing doctors to place him on a ventilator. At one point, his situation became so dire that a priest was called to administer last rites.
But by Tuesday, everything changed.
“He’s a fighter — the way he was yesterday in such a critical condition, he did have a priest come anoint him,” Ryan said. “And all the prayers from around — it’s like a miracle. This guy’s got 9 lives, today he’s doing much better.”
Goodman said Giuliani was previously diagnosed with restrictive airway disease, which he said was a result of his proximity to the collapsed World Trade Center towers on Sept. 11, 2001.
“This condition adds complications to any respiratory illness, and the virus quickly overwhelmed his body, requiring mechanical ventilation to maintain adequate oxygen and stabilize his condition,” Goodman said Monday.
The former New York City mayor is now breathing on his own after doctors removed him from a ventilator, marking a dramatic turnaround from what had been a life-threatening condition just hours earlier.
Dr. Maria Ryan told Fox News that Giuliani’s condition had deteriorated rapidly after he returned from a trip to Paris, with severe breathing issues forcing doctors to place him on a ventilator. At one point, his situation became so dire that a priest was called to administer last rites.
But by Tuesday, everything changed.
“He’s a fighter — the way he was yesterday in such a critical condition, he did have a priest come anoint him,” Ryan said. “And all the prayers from around — it’s like a miracle. This guy’s got 9 lives, today he’s doing much better.”
Giuliani, 81, is now off the ventilator, breathing independently, and able to speak, though he remains in critical but stable condition. Ryan said she expects him to make a full recovery.
A spokesperson for Giuliani pointed to the long-term health toll of his time at Ground Zero following the September 11 attacks, where exposure to toxic debris led to a diagnosis of restrictive airway disease — a condition that can make respiratory illnesses far more dangerous.
In a video update, spokesman Ted Goodman confirmed the improvement.
“Mayor Rudy Giuliani is the ultimate fighter,” Goodman said, adding that he is now “breathing on his own” while continuing to recover.
The scare comes after a series of health challenges in recent years, including a serious car crash in New Hampshire in 2025 that left Giuliani with a fractured vertebra and multiple injuries.
Yet once again, he’s defying the odds.
Doctors say the latest improvement could mark a turning point, though he remains under close monitoring in the days ahead.
An adviser to President-elect Trump’s campaign, Alex Bruesewitz, passed out and collapsed as he was speaking onstage during a New York Young Republican Club gala Sunday night.
Alex Bruesewitz, 27, was introducing incoming White House senior aide Dan Scavino inside a venue in Manhattan when he began stumbling over his words and fainted, video on social media shows.
Several people quickly rushed to help after his collapse. It was not immediately clear what caused him to faint.
“I talked to our friend Alex Bruesewitz and you know what he said to me? He goes ‘Did I at least look cool?’ I said Alex, you used gravity like I’ve seen nobody use gravity before in their lives,” Kassam said. “But he’s recuperating back there, so give him a big cheer so he’ll hear you.”
Trump also said following the collapse that he believes Bruesewitz will be fine, according to the New York Post.
“I know that Alex is going to be fine because he’s a tough son of a gun,” Trump said. “There’s no doubt about that. So I want to say hello to Alex, because he’s a very special guy.”
Bruesewitz is the CEO of consultancy firm X Strategies LLC, which states its mission to help elect “America First” candidates. Its website says he is “a prominent political consultant and strategist known for his unwavering support of President Donald Trump and the America First agenda.”
Before his collapse, Bruesewitz commended the New York Republican Club for backing Trump’s campaign. He also gave shout-outs to several supporters of the incoming president who were at the event, including former Florida congressman Matt Gaetz, who recently resigned from his U.S. House seat.
President Donald Trump participates in a welcome ceremony with Saudi Crown Prince Mohammed Bin Salman Al Saud at the Royal Court Palace in Riyadh, Saudi Arabia, Tuesday, May 13, 2025. (Official White House Photo by Daniel Torok)
President Donald Trump will have his annual medical checkup at a hospital near Washington on May 26, the White House said Monday night.
The oldest person ever inaugurated as President, Trump, turns 80 in June. Trump traveled to China for a summit with that country’s leader, Xi Jinping this week.
Read the full statement from the White House:
President Donald J. Trump will visit Walter Reed National Military Medical Center on May 26 for his annual dental and medical evaluations, and to visit with the men and women of the military. This will include the President’s routine annual dental and medical assessments as part of his regular preventive health care. The President will also spend time with service members and staff at Walter Reed in recognition of their service, professionalism, and dedication to the nation. Additional details regarding the President’s schedule will be released at a later date.
In March, the White House doctor said the president was taking a prescription “preventative skin treatment” to treat irritation on his neck.
Last July, the White House said Trump had been diagnosed with chronic venous insufficiency, a common condition tied to swelling in the legs, but that doctors had otherwise found the president to be in “excellent health.”
The White House, Public domain, via Wikimedia Commons
New York Attorney General Letitia James (D) sued the federal government Tuesday, arguing that a new Department of Health and Human Services (HHS) policy unlawfully ties major federal funding streams to compliance with the Trump administration’s new restrictions on gender-related medical care for minors.
The lawsuit challenges an HHS policy that, according to the attorneys general, conditions billions of dollars in health, education and research funding on compliance with a presidential executive order addressing sex and gender-related treatments.
“The federal government is trying to force states to choose between their values and the vital funding their residents depend on,” James said in a statement. “This policy threatens healthcare for families, life-saving research, and education programs that help young people thrive in favor of denying the dignity and existence of transgender people.”
The dispute stems from President Donald Trump’s January 2025 executive order directing HHS to take steps to curb what the administration calls “chemical and surgical mutilation” of children. President Trump has made limits on transgender-related medical care for minors a central part of his second-term domestic agenda.
NYC Public Advocate Tish James via Wikimedia Commons
Last month, HHS announced a sweeping package of proposed regulatory actions aimed at ending what it described as “sex-rejecting procedures” for minors. In guidance accompanying the announcement, the department warned that doctors and health systems could be excluded from federal health programs — including Medicare and Medicaid — if they provide treatments such as puberty blockers, hormone therapy, and gender surgeries to minors.
James’ lawsuit argues that the federal government is using funding leverage to pressure states, hospitals, universities, and other institutions to change policies on transgender care.
The attorneys general also claim HHS lacks legal authority to impose the conditions and is attempting to rewrite federal law through executive action. They argue the policy is vague and fails to spell out what recipients must do to remain compliant, creating uncertainty for states and institutions that rely on federal dollars.
Failure to comply with the policy could lead to termination of grants, repayment of funds already spent, or potential civil or criminal penalties, according to the complaint.
The lawsuit asks a federal court to declare the policy unlawful and block HHS from enforcing it, allowing states and institutions to continue receiving federal funding without changing existing policies.
The legal fight also adds to the long-running political and courtroom clash between Trump and James. James has positioned herself as one of the country’s most aggressive state-level opponents of Trump, repeatedly using New York’s legal powers to pursue high-profile cases involving his businesses and allies. Trump has frequently accused James of pursuing politically motivated investigations.
Trump officials have defended the executive order as a child-protection measure and a pushback against what they say is ideological medicine being imposed through federal agencies and school systems.
The case is expected to intensify a national debate already playing out in Congress and state legislatures, where Republican-led states have moved to restrict or ban gender-related treatments for minors, while Democrat-led states have expanded protections and access.
Outgoing Director of National Intelligence Tulsi Gabbard shared an encouraging update Thursday on her husband’s battle with a rare form of bone cancer, revealing that a major surgery to remove the tumor was successful.
Gabbard said her husband, Abraham Williams, recently underwent a nearly seven-hour operation after being diagnosed with sacral chordoma, an extremely rare cancer that forms in the bones of the spine and skull base.
“The surgery to remove bone and surrounding tissue lasted almost seven hours and was successful,” Gabbard wrote in a post on X.
“He had a rough night and is in a lot of pain, but is finally home resting.”
The Trump administration official said the family is now focused on the recovery process.
“Now recovery begins. We’re so grateful for the outpouring of prayers and kind messages from all of you. Our hearts are full,” Gabbard added.
My husband Abraham was diagnosed with a very rare sacral chordoma. The surgery to remove bone and surrounding tissue lasted almost seven hours and was successful. He had a rough night and is in a lot of pain but is finally home resting. Now recovery begins. We’re so grateful…
According to Mayo Clinic research, sacral chordoma is a rare, slow-growing bone cancer that most commonly develops along the spine. While considered slow-growing, the disease can be difficult to treat because of its location, and surgery is often the primary treatment option.
Before the procedure, Gabbard shared a heartfelt message thanking supporters for their prayers.
“We are humbled and so grateful to be surrounded by aloha during this really tough time,” she wrote.
The update comes just weeks after Gabbard announced she would step down from her position in the Trump administration to support her husband through the difficult battle ahead. (RELATED:Tulsi Gabbard Resigning As National Intelligence Director)
“My husband, Abraham, has recently been diagnosed with an extremely rare form of bone cancer,” Gabbard wrote in May. “He faces major challenges in the coming weeks and months. At this time, I must step away from public service to be by his side and fully support him through this battle.”
President Donald Trump praised Gabbard following her resignation announcement, saying she had done “an incredible job” serving in his administration.
Vice President JD Vance also voiced support for the former Hawaii congresswoman.
“I’m sorry to see her go, but certainly understand that family comes first,” Vance said. “She and her husband Abraham will be in my prayers as they face this next challenge together, and she has my gratitude for being a great addition to the administration and a loyal confidante. Godspeed Tulsi!”
Gabbard’s final day in office is expected to be June 30.
The White House has also tapped Federal Housing Finance Agency Director William J. “Bill” Pulte to assume Gabbard’s intelligence role following her departure.
Gabbard, a former Democrat congresswoman from Hawaii, became one of the most prominent political converts of the 2024 election cycle when she endorsed Trump’s presidential campaign and later joined his administration.
The White House, Public domain, via Wikimedia Commons
President Donald Trump has selected Dr. Heidi Overton, a senior White House domestic policy adviser and physician, to lead the Food and Drug Administration as the agency confronts battles over vaccines, drug prices, food additives, and abortion medication.
Trump announced the nomination Wednesday, describing Overton as a trusted problem-solver who would accelerate medical innovation, lower prescription costs, and advance Health and Human Services Secretary Robert F. Kennedy Jr.’s “Make America Healthy Again” agenda.
Overton currently serves as deputy director of the White House Domestic Policy Council, where she has helped formulate and promote several of the administration’s most consequential health initiatives.
BREAKING: President Trump picks Dr. Heidi Overton, a top White House aide, to lead the Food and Drug Administration. https://t.co/fGVJ7TNQjt
If confirmed by the Senate, she would succeed Dr. Marty Makary, who left the agency in May after a turbulent tenure marked by internal disputes and disagreements over the direction of federal health policy.
Kyle Diamantas, who previously led the FDA’s Human Foods Program, is serving as acting commissioner.
A Physician With Deep White House Ties
Overton is a board-certified physician in public health and general preventive medicine. She earned her medical degree from the University of New Mexico School of Medicine and a doctorate in clinical investigation from the Johns Hopkins Bloomberg School of Public Health.
She previously trained as a general surgery resident at Johns Hopkins and advocated for greater price and quality transparency in health care.
During medical school, then-New Mexico Gov. Susana Martinez appointed Overton to the University of New Mexico Board of Regents, where she held voting and fiduciary responsibility for the university and its health system.
Overton first entered the Trump White House as a fellow in 2019, working in the Office of American Innovation and on the Domestic Policy Council. Between Trump’s terms, she served as chief policy officer at the America First Policy Institute and helped lead its Center for a Healthy America.
Her biography from the conservative organization emphasizes her work on health-care transparency, fentanyl, public health and policies designed to give patients greater control over medical decisions.
The appointment would place a committed administration loyalist at the head of an agency that regulates products representing roughly one-fifth of American consumer spending.
Overton Helped Shape Trump’s Health Agenda
Overton has appeared alongside Trump during major health policy announcements, including the administration’s efforts to negotiate “most favored nation” agreements with drug companies. The policy seeks to tie American prescription prices to the lower prices paid in other developed countries.
She was also involved in Trump’s controversial effort to revise the childhood vaccination schedule and separate the combined measles, mumps and rubella vaccine into three individual shots.
Major medical organizations have generally supported the combined MMR vaccine, which has been used for decades and reduces the number of clinical visits and injections required for full immunization. Critics fear that splitting the vaccine could create delays and lower vaccination rates.
Overton’s role in the policy is likely to become a focus of her Senate confirmation hearing, particularly as lawmakers question how she would handle pressure from Kennedy and other administration figures skeptical of established federal vaccine recommendations.
Trump praised Overton as a “rockstar” who would advance medical cures, innovation and lower drug prices.
Kennedy also supports the nomination, giving Overton an important ally inside the Department of Health and Human Services, which oversees the FDA.
Difficult Issues Await New Commissioner
The next FDA commissioner will inherit an unusually difficult collection of unfinished projects.
The agency continues to face pressure over its regulation of COVID-19 vaccines and other immunizations, including questions about which populations should receive updated shots and what evidence manufacturers must provide.
Medication abortion will present another immediate test. Pro-life organizations want the FDA to impose tighter restrictions on mifepristone, including limits on prescriptions issued through telehealth and pills delivered through the mail.
Overton has previously used the term “teleabortion” when discussing remote access to abortion medication, drawing concern from abortion-rights organizations that expect her to revisit the drug’s rules.
The FDA must also determine how aggressively it will regulate ultraprocessed foods, chemical additives, and synthetic dyes. Those issues are central to Kennedy’s MAHA movement but can conflict with the deregulatory approach traditionally favored by Republican lawmakers and industry groups.
Other pending questions involve flavored electronic cigarettes, peptide treatments, psychedelics, antidepressant warnings, and efforts to shorten the approval process for new drugs.
Overton would therefore have to balance three competing forces: Trump’s desire for faster approvals and lower prices, Kennedy’s campaign against corporate influence in food and medicine, and Republican demands for reduced federal regulation.
Management Experience Likely to Draw Scrutiny
Overton’s supporters point to her medical education, policy background, and proximity to presidential decision-making. They argue that she understands Trump’s priorities and can coordinate more effectively with the White House than an outside nominee.
Critics are expected to focus on her limited experience running an organization comparable to the FDA.
The agency employs thousands of scientists, physicians, inspectors, lawyers, and regulatory specialists. It oversees prescription drugs, medical devices, vaccines, tobacco products, much of the nation’s food supply, and other consumer goods.
Axios reported before her selection that some health policy observers worried Overton’s nomination could unsettle FDA career employees and pharmaceutical investors, while other potential candidates possessed more direct executive management experience.
The criticism will likely feature prominently when she appears before the Senate Health, Education, Labor and Pensions Committee.
Makary, Overton’s predecessor and a former Johns Hopkins colleague, was confirmed in March 2025 by a 56-44 Senate vote. Overton will seek confirmation from a chamber still controlled by Republicans but divided over the administration’s vaccine policies.
Her nomination signals that Trump wants the FDA led by someone already embedded in his White House rather than an agency insider or pharmaceutical executive.
If the Senate agrees, Overton will take control of one of the federal government’s most powerful scientific agencies — and become responsible for turning the administration’s sprawling health agenda into enforceable policy.
The White House, Public domain, via Wikimedia Commons
President Donald Trump expressed sympathy for former President Joe Biden following Sunday’s surprise announcement of Biden’s aggressive prostate cancer diagnosis. In a Truth Social post, Trump stated:
“Melania and I are saddened to hear about Joe Biden’s recent medical diagnosis. We extend our warmest and best wishes to Jill and the family, and we wish Joe a fast and successful recovery.”
Biden, 82, was diagnosed with a high-grade, hormone-sensitive prostate cancer that has metastasized to the bone. Biden and his family are currently reviewing treatment plans with his medical team.
Trump’s message marks a notable moment of bipartisan compassion amid ongoing political tensions.
In his first public statement following the diagnosis, Biden expressed gratitude for the outpouring of support, saying:
“Cancer touches us all. Like so many of you, Jill and I have learned that we are the strongest in broken places.”
The announcement has prompted a wave of bipartisan support, with messages of encouragement from various political figures, including Kamala Harris and Barack Obama.
However, not all reactions have been as supportive. Donald Trump Jr. initially shared a message wishing President Biden a speedy recovery but later posted a controversial comment questioning how Dr. Jill Biden could have missed signs of advanced cancer, suggesting a possible cover-up. “What I want to know is how did Dr. Jill Biden miss stage five metastatic cancer—or is this yet another cover-up???” Trump Jr. wrote on X (formerly Twitter). His post was widely criticized for its accusatory tone and for failing to note that Jill Biden holds a doctorate in education, not medicine.
According to Newsweek‘s reporting, the cancer presumably developed rapidly, despite Biden’s routine screenings intended to detect it early:
A professor of oncology told Newsweek that Joe Biden would have been tested for prostate cancer while in office and it is likely his cancer developed rapidly.
Gage Skidmore, CC BY-SA 2.0 , via Wikimedia Commons
Biden’s age and health were dominant concerns among voters during his time as president. The 82-year-old dismissed concerns about his mental acuity, but ultimately dropped his bid for a second term following a disastrous debate performance in June last year. He was replaced as the Democratic nominee by then-Vice President Kamala Harris, who lost to President Donald Trump.
Questions have been raised about the Biden administration and campaign’s transparency about Biden’s age and cognitive ability. An upcoming book alleges White House aides covered up Biden’s physical and mental decline. However, there is no current indication publicly available that Biden was diagnosed with prostate cancer during his tenure as president.
…
Biden’s office said the former president was diagnosed with prostate cancer on Friday, with the cancer cells having spread to the bone.